Pegfilgrastim biosimilar (Zydus Cadila)

培非格司亭生物类似药 (Zydus Cadila)

Report date: 2022/01/21 13:30:11

Base Information

Drug NamePegfilgrastim biosimilar (Zydus Cadila)
Drug Alias Name非格司亭生物仿制药 (Zydus Cadila)Peg G-CSF (Zydus Cadila)培非司亭生物仿制药 (Zydus Cadila)
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsNeutropenia
Global Approved IndicationsNeutropenia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2014/01/01
Country/TerritoryIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesZydus Cadila
China Registration ClassN/A

Develop Information

Active CompaniesZydus Cadila
Inactive CompaniesN/A
Active IndicationsNeutropenia
Inactive IndicationsN/A

Other Information

ATC CodeL03AA13
Related LinksN/A